Cost-effectiveness of population-level expansion of highly active antiretroviral treatment for HIV in British Columbia, Canada: a modelling study.
about
What Triggers a Diagnosis of HIV Infection in the Tokyo Metropolitan Area? Implications for Preventing the Spread of HIV Infection in Japan.Cost-Effectiveness of the 'One4All' HIV Linkage Intervention in Guangxi Zhuang Autonomous Region, China.Initiating HCV treatment with direct acting agents in opioid agonist treatment: When to start for people co-infected with HIV?Relative effects of antiretroviral therapy and harm reduction initiatives on HIV incidence in British Columbia, Canada, 1996-2013: a modelling study.HIV treatment as prevention among people who inject drugs - a re-evaluation of the evidence.Differences in health-related quality of life between HIV-positive and HIV-negative people in Zambia and South Africa: a cross-sectional baseline survey of the HPTN 071 (PopART) trialA historical review of HIV prevention and care initiatives in British Columbia, Canada: 1996-2015Highlights of the International Congress on Drug Therapy in HIV Infection, 23-26 October 2016, Glasgow, UK.Characterizing Human Immunodeficiency Virus Antiretroviral Therapy Interruption and Resulting Disease Progression Using Population-Level Data in British Columbia, 1996-2015.Belief in Treatment as Prevention and Its Relationship to HIV Status and Behavioral Risk.Progress towards the United Nations 90-90-90 and 95-95-95 targets: the experience in British Columbia, Canada.The cost-effectiveness of HIV testing and treatment engagement initiatives in British Columbia, Canada: 2011-2013.Cost-Utility of Access to Care, a National HIV Linkage, Re-engagement and Retention in Care Program.
P2860
Q35852492-35771727-8434-41E2-A768-4753C21C23C3Q36205807-F3AFE5A9-6ED2-4EE1-AFEF-191333DE0871Q38746105-846BD3F2-60C4-41F7-85BE-3B25BD4D7E0AQ38861807-0D5D969A-D002-44FD-8F88-E0DA7F458B71Q40622144-76EE1E69-6355-4B3A-A3FC-4431B880F7E7Q41927394-542D3D65-4D33-4EFB-8CBD-FE6B6B6B9CB0Q41993740-23BD46AD-5F91-45C7-B4A8-25092E175222Q42365529-3E529FB6-FE74-4272-A14C-50A562E35954Q45326055-74E07271-F2FD-472A-A889-50F9C0573C06Q47189547-E48BF6FF-3088-43B4-984B-D8BCE48A1CD4Q47582376-804CC668-5696-4742-A406-C398676A6FE4Q47801305-92E41F05-5EAC-4E83-9979-313C989C058CQ50181445-D56B5004-BD7C-46F1-8A0F-451BFF2010E8
P2860
Cost-effectiveness of population-level expansion of highly active antiretroviral treatment for HIV in British Columbia, Canada: a modelling study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Cost-effectiveness of populati ...... ia, Canada: a modelling study.
@ast
Cost-effectiveness of populati ...... ia, Canada: a modelling study.
@en
type
label
Cost-effectiveness of populati ...... ia, Canada: a modelling study.
@ast
Cost-effectiveness of populati ...... ia, Canada: a modelling study.
@en
prefLabel
Cost-effectiveness of populati ...... ia, Canada: a modelling study.
@ast
Cost-effectiveness of populati ...... ia, Canada: a modelling study.
@en
P2093
P2860
P1433
P1476
Cost-effectiveness of populati ...... ia, Canada: a modelling study.
@en
P2093
Bohdan Nosyk
Jeong E Min
STOP HIV/AIDS study group
Viviane D Lima
P2860
P304
P356
10.1016/S2352-3018(15)00127-7
P577
2015-07-16T00:00:00Z